TIME FOR LIFE

T-MAB

Trastuzumab

Lyophilisate for concentrate for solution for infusion

  • Antineoplastic agents. Monoclonal antibodies.
  • Trastuzumab is a recombinant humanised IgG1 monoclonal antibody that interferes with the HER2/neu receptor. Additionally, trastuzumab is a potent mediator of antibody-dependent cell-mediated cytotoxicity (ADCC).
  • T-MAB is approved to first-line treatment of patients with breast and stomach cancer.
  • Monoclonal antibody against the human epidermal growth factor receptor 2 (HER2).